%A Jia Youchao, Shang Yanhong, Zang Aimin %T Applications of molecular detection of lung cancer in developing countries %0 Journal Article %D 2014 %J Journal of International Oncology %R 10.3760/cma.j.issn.1673-422X.2014.01.015 %P 47-49 %V 41 %N 1 %U {https://gjzlx.sdfmu.edu.cn/CN/abstract/article_9278.shtml} %8 2014-01-08 %X The era of personalized medicine of nonsmall cell lung cancer has arrived. Gene detecrion is part of the daily clinical decision, at least for patients with adenocarcinoma. Access to those tests is still very limited in the developing world: quality control, reimbursement/cost and widespread access. Because of the differences in the national conditions of developing countries, strategies certainly vary from country to country. Molecular epidemiology data generated by developing countries, as well as the use of their emerging scientific and technologic capacities to generate and validate novel biomarkers and diagnostic kits, will certainly contribute to better treatment of patients with lung cancer worldwide.